CIK 0001374690 · Non-accelerated filer<br>Smaller reporting company
Larimar Therapeutics, Inc.
Sign in to watch- Ticker
- LRMR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203857670
- Phone
- 844-511-9056
- Business address
- THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
- Former names
- ZAFGEN, INC., ZAFGEN INC
- Open-market buys, last 90 days
- $382,086
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$382,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | Hamilton Thomas Edward Director | Purchase | +70,000 | $2.67 | $187K | 70,000 |
| 2026-11-11 | BEN-MAIMON CAROLE President and CEO | Purchase | +18,050 | $2.77 | $50K | 386,326 |
| 2026-11-11 | THOMAS FRANK E Director | Purchase | +8,000 | $2.73 | $22K | 15,000 |
| 2026-11-11 | Truitt Joseph Director | Purchase | +3,500 | $2.80 | $10K | 6,250 |
| 2026-11-11 | Harlow John B. Jr. President and COO | Purchase | +17,800 | $2.80 | $50K | 67,800 |
| 2026-11-11 | Celano Michael Chief Financial Officer | Purchase | +18,460 | $2.71 | $50K | 234,245 |
| 2026-11-11 | Shankar Gopi Chief Development Officer | Purchase | +5,000 | $2.71 | $14K | 81,443 |
| 2026-09-29 | Harlow John B. Jr. President and COO | Grant or award | +50,000 | 50,000 | ||
| 2026-09-29 | Harlow John B. Jr. President and COO | Grant or award · Stock Option (Right to Buy) | +800,000 | 800,000 | ||
| 2026-07-06 | Hamilton Thomas Edward Director | Purchase | +50,000 | $3.34 | $167K | 714,798 |
| 2026-05-19 | Flynn James E Director | Grant or award · Stock Option (Right to Buy) | +55,150 | 55,150 | ||
| 2026-05-19 | LEFF JONATHAN S Director | Grant or award · Stock Option (Right to Buy) | +55,150 | 55,150 | ||
| 2026-05-19 | SHERMAN JEFFREY W Director | Grant or award · Stock Option (Right to Buy) | +55,150 | 55,150 | ||
| 2026-05-19 | Truitt Joseph Director | Grant or award · Stock Option (Right to Buy) | +55,150 | 55,150 | ||
| 2026-05-19 | THOMAS FRANK E Director | Grant or award · Stock Option (Right to Buy) | +55,150 | 55,150 | ||
| 2026-05-19 | Hamilton Thomas Edward Director | Grant or award · Stock Option (Right to Buy) | +55,150 | 55,150 | ||
| 2026-02-27 | Flynn James E Director | Purchase | +1,084,010 | $5.00 | $5.4M | 10,622,928 |
| 2026-02-27 | Flynn James E Director | Purchase | +1,084,012 | $5.00 | $5.4M | 10,622,957 |
| 2026-02-27 | Flynn James E Director | Purchase | +831,978 | $5.00 | $4.2M | 8,153,107 |
| 2026-02-27 | Flynn James E Director | Purchase | +2,000,000 | $5.00 | $10.0M | 6,207,982 |
Page 1 of 7 · 136 trades